Treatment of psoriatic arthritis with etanercept.
Kurschat
P
P
Rubbert
A
A
Poswig
A
A
Scharffetter-Kochanek
K
K
Krieg
T
T
Hunzelmann
N
N
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000473:pathology; D002097:C-Reactive Protein / Q000032:analysis; D006233:Persons with Disabilities; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000494:pharmacology*; D007249:Inflammation; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010146:Pain; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D016896:Treatment Outcome; D016138:Walking
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D002097:C-Reactive Protein; D000068800:Etanercept